在癌症中超强增强器重编程和激活的病因学
Royce W Zhou1,2,3, Ramon E Parsons4,5
1The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Epigenetics & chromatin
|July 6, 2023
概括
超级增强剂调节细胞身份基因,并在瘤发生过程中发生变化. 异常的超级增强剂激活癌症驱动基因,促进瘤生长和生存.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 超级增强剂是控制细胞身份基因的关键调控元素.
- 瘤生成的特点是超级增强器景观的显著变化.
- 异常的超级增强剂可以激活瘤基因和癌细胞存活所必需的基因.
研究的目的:
- 审查细胞内在和细胞外在的驱动癌症超强增强器变化的因素.
- 突出超级增强剂在激活促进癌症的基因中的作用,例如MYC.
- 讨论瘤微环境对超强增强器变化的影响.
主要方法:
- 对超级增强剂和癌症基因组学现有文献的审查.
- 对推动瘤中超强增强剂形成和功能机制的分析.
- 影响超级增强景观的遗传,表观遗传和环境因素的整合.
主要成果:
- 超级增强剂在癌症中经常被重新编程,以驱动瘤基因表达.
- 与癌症相关的超级增强剂调节了增殖和生存的关键基因.
- 作为扩散的主调节者,MYC通常由癌症中获得的超级增强剂控制.
结论:
- 超强增强剂的改变是癌症的标志,有助于瘤发生和进展.
- 了解这些变化为针对癌细胞依赖性的新型治疗策略提供了洞察力.
- 遗传变化和瘤微环境都在塑造癌症中异常的超级增强器格局中发挥着至关重要的作用.
相关概念视频
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K


